{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:27:49Z","timestamp":1786969669535,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Gynecological malignancies, particularly ovarian and endometrial cancers, primarily contribute to cancer-related morbidity and mortality across the world and in India. Debulking surgery is still the cornerstone of treatment for advanced cases, but these procedures are associated with significant perioperative risks that can impact recovery and delay adjuvant therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study intends to identify predictors of 30-day postoperative morbidity and 90-day mortality following debulking surgeries for gynecological malignancies in an Indian tertiary care setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective observational study was conducted at the National Cancer Institute, AIIMS Jhajjar, including 100 patients who underwent debulking surgery for ovarian, endometrial, or cervical malignancies between January 2022 and June 2023. Data on demographics, disease stage, surgical details, intraoperative events, and postoperative outcomes were collected. Univariate and multivariable logistic regression analyses were performed to identify significant predictors of morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Major 30-day morbidity occurred in 42% of patients, while no 90-day mortality was noted. On univariate analysis, surgical duration &gt;300 min (odds ratio (OR) 2.72[95% confidence interval {CI} 1.15 to 6.44]; P = 0.021), sustained hypotension (OR 2.67[95% CI 1.05 to 6.75]; P = 0.035), blood loss \u2265500 ml (OR 2.56[95% CI 1.11 to 5.89]; P = 0.025), and intraoperative blood transfusion (OR 3.70[95% CI 1.60 to 8.53]; P = 0.002) were significantly associated with increased morbidity. Multivariable analysis revealed that intermediate or high surgical complexity was protective against 30-day morbidity (OR 0.163 [95% CI 0.034 to 0.792]; P = 0.025), which can be attributed to careful patient selection and better perioperative optimization of high-risk patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Prolonged surgery, increased blood loss, and hemodynamic instability are decisive predictors of postoperative morbidity. Selection and perioperative optimization enable safe performance of complex debulking procedures in appropriate patients. Employing structured risk stratification and targeted perioperative interventions is essential for improving postoperative outcomes in this population. Prospective validation and assessment of these strategies should be emphasized.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1652_25","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:00:25Z","timestamp":1786780825000},"page":"540-547","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of postoperative morbidity after debulking surgeries for gynecological malignancies"],"prefix":"10.4103","volume":"22","author":[{"given":"Juhi","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Onco-Anaesthesia and Palliative Medicine, Dr. BRAIRCH and NCI Jhajjar, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Kumari","sequence":"additional","affiliation":[{"name":"Gynecology Oncology, Department of Surgical Oncology, Max Dwarka, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Vig","sequence":"additional","affiliation":[{"name":"Department of Onco-Anaesthesia and Palliative Medicine, NCI, Jhajjar, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Statistics, Delhi Cancer Registryr, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek","family":"Maurya","sequence":"additional","affiliation":[{"name":"Department of Onco-Anaesthesia and Palliative Medicine, NCI, Jhajjar, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Bhan","sequence":"additional","affiliation":[{"name":"Department of Onco-Anaesthesia, Delhi State Cancer Institute, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Sirohiya","sequence":"additional","affiliation":[{"name":"Department of Onco-Anaesthesia and Palliative Medicine, NCI, Jhajjar, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balbir","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Onco-Anaesthesia and Palliative Medicine, NCI, Jhajjar, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Onco-Anaesthesia and Palliative Medicine, Dr. BRAIRCH and NCI Jhajjar, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"04155","DOI":"10.7189\/jogh.14.04155","article-title":"Global burden of gynaecological cancers in 2022 and projections to 2050","volume":"14","author":"Zhu","year":"2024","journal-title":"J Glob Health"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4103\/ijmr.ijmr_1821_22","article-title":"Cancer incidence estimates for 2022 and projection for 2025: Result from national cancer registry programme, India","volume":"156","author":"Sathishkumar","year":"2022","journal-title":"Indian J Med Res"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40944-022-00694-1","article-title":"Descriptive epidemiology of ovarian cancers in India: A report from national cancer registry programme","volume":"21","author":"Chaturvedi","year":"2023","journal-title":"Indian J Gynecol Oncolog"},{"key":"R5-20260817","first-page":"280","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.3390\/cancers14184500","article-title":"Current approaches to the management of patients with endometrial cancer","volume":"14","author":"Kalampokas","year":"2022","journal-title":"Cancers"},{"key":"R7-20260817","first-page":"781","article-title":"Comparative analyses of postoperative complications and prognosis of different surgical procedures in stage II endometrial carcinoma treatment","volume":"9","author":"Yin","year":"2016","journal-title":"Onco Targets Ther"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jss.2019.08.027","article-title":"Complications and survivorship trends after primary debulking surgery for ovarian cancer","volume":"246","author":"Xu","year":"2020","journal-title":"J Surg Res"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/healthcare7030085","article-title":"Clinical factors associated with longer hospital stay following ovarian cancer surgery","volume":"7","author":"Smith","year":"2019","journal-title":"Healthcare (Basel)"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ygyno.2021.06.003","article-title":"Performance validation of the Mayo triage algorithm applied to individualize surgical management of advanced epithelial ovarian cancer","volume":"162","author":"Jiang","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"676.e1","DOI":"10.1016\/j.ajog.2007.10.495","article-title":"Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer","volume":"197","author":"Aletti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"(Suppl 3)","key":"R12-20260817","doi-asserted-by":"crossref","first-page":"A114","DOI":"10.1136\/ijgc-2019-IGCS.269","article-title":"269 A prospective study of factors predicting morbidity and mortality in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian malignancy","volume":"29","author":"Ahuja","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"R13-20260817","first-page":"e21409","article-title":"Preoperative predictors of optimal tumor resectability in patients with epithelial ovarian cancer","volume":"14","author":"Okunade","year":"2022","journal-title":"Cureus"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4103\/0019-509X.104494","article-title":"Profile of gynecologic malignancies reported at a tertiary care center in India over the past decade: Comparative evaluation with international data","volume":"49","author":"Malhotra","year":"2012","journal-title":"Indian J Cancer"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3802\/jgo.2009.20.2.77","article-title":"Current status of gynecological cancer care in India","volume":"20","author":"Uma Devi","year":"2009","journal-title":"J Gynecol Oncol"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"R18-20260817","article-title":"The life and times of low-grade serous carcinoma of the ovary. InAmerican Society of Clinical Oncology Educational book","author":"Gershenson","journal-title":"American Society of Clinical Oncology. Annual Meeting 2013 Jan 1"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3390\/biomedicines13061305","article-title":"Prognostic significance of delays in initiation of adjuvant trastuzumab-based therapy in patients with HER2-positive breast cancer","volume":"13","author":"Dowling","year":"2025","journal-title":"Biomedicines"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejca.2009.10.017","article-title":"Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer","volume":"46","author":"Gerestein","year":"2010","journal-title":"Eur J Cancer"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1097\/IGC.0000000000001325","article-title":"Predictive factors for surgical morbidities and adjuvant chemotherapy delay for advanced ovarian cancer patients treated by primary debulking surgery or interval debulking surgery","volume":"28","author":"Castro","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.3802\/jgo.2022.33.e53","article-title":"Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: A systematic review and meta-analysis","volume":"33","author":"Kengsakul","year":"2022","journal-title":"J Gynecol Oncol"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"e0178610","DOI":"10.1371\/journal.pone.0178610","article-title":"Prediction model for 30-day morbidity after gynecological malignancy surgery","volume":"12","author":"Shim","year":"2017","journal-title":"PLoS One"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2010.05.031","article-title":"The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas","volume":"119","author":"Chi","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41551-022-00860-y","article-title":"Detection of ovarian cancer via the spectral fingerprinting of quantum-defect-modified carbon nanotubes in serum by machine learning","volume":"6","author":"Kim","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"R26-20260817","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/ijgc-2022-003799","article-title":"Validation of a risk-based algorithm to reduce poor operative outcomes after complex surgery for ovarian cancer","volume":"33","author":"Narasimhulu","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"R27-20260817","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1016\/S1470-2045(21)00181-9","article-title":"Secondary cytoreduction for relapsed ovarian cancer","volume":"22","author":"Garg","year":"2021","journal-title":"Lancet Oncol"},{"key":"R28-20260817","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"R29-20260817","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-8258(92)90100-W","article-title":"The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A gynecologic oncology group study","volume":"47","author":"Hoskins","year":"1992","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1652_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:01:39Z","timestamp":1786968099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1652_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1652_25","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-08-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}